# 바이오스페이스 일일 뉴스 리포트 - 2025년 04월 16일


## 주요 헤드라인

1. **Sanofi’s $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/sanofis-1-4b-kymab-bet-falters-as-asthma-drug-stumbles-in-phase-ii>

2. **Sanofi’s $1.4B Kymab Bet Falters as Asthma Drug Stumbles in Phase II (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/sanofis-1-4b-kymab-bet-falters-as-asthma-drug-stumbles-in-phase-ii>

3. **With Tariffs Looming, EU and US Pharmas Make Demands of European Commission (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/with-tariffs-looming-eu-and-us-pharmas-make-demands-of-european-commission>

4. **With Tariffs Looming, EU and US Pharmas Make Demands of European Commission (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/with-tariffs-looming-eu-and-us-pharmas-make-demands-of-european-commission>

5. **‘Finally, Some Good News’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/finally-some-good-news-trump-signals-support-for-removing-iras-pill-penalty>

6. **‘Finally, Some Good News’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/finally-some-good-news-trump-signals-support-for-removing-iras-pill-penalty>

7. **Glycomine Gets $115M Series C for Rare Disease, Aims for Phase II Launch Mid-Year (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/glycomine-gets-115m-series-c-for-rare-disease-aims-for-phase-ii-launch-mid-year>


---
*2025년 04월 16일 바이오스페이스 뉴스 피드에서 생성된 리포트*